Global Oncology Drug Market Overview:
Global Oncology Drug Market Report 2024 provides a comprehensive analysis of the industry, covering key factors such as market trends, growth drivers, developments, size, and dynamics. The report also calculates present and past market values to forecast potential market management through the forecast period between 2024-2032.This research study of Oncology Drug involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Oncology Drug Market
The Oncology Drug Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Oncology Drug Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting the growth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Oncology Drug Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Oncology Drug market has been segmented into:
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy
Others
By Application, Oncology Drug market has been segmented into:
Blood Cancer
Breast Cancer
gastrointestinal Tract Cancer
Prostate Cancer
Lung Cancer
Skin Cancer
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East and Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Oncology Drug market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Oncology Drug market.
Top Key Players Covered in Oncology Drug market are:
Roche Ltd
Novartis AG
Bristol-Myers Squibb
Celgene Corporation
Johnson and Johnson
Pfizer Inc.
Astra Zenca Plc
Eli Lilly And Company.
Glaxosmithkline Plc
Merck and Co.
Sanofi
Amgen Inc.
Abbvie
Research Methodology:
Our report provides a detailed breakdown of the market, divided into segments like Type and Application, each with its own sub-categories. We also examine major competitors, looking at their market size, share, and recent activities such as mergers, acquisitions, and partnerships. This helps new and existing businesses in the Oncology Drug Market understand the competitive landscape and plan their strategies. We collect our data through two main methods:
1. Primary Research: Direct interviews with industry experts and insights from top research analysts.
2. Secondary Research: Information from company annual reports and public records.
We then analyze this data using proven methods like SWOT analysis, PORTER's Five Forces model, and PESTLE analysis to ensure accuracy and reliability.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Oncology Drug Market by Type
4.1 Oncology Drug Market Snapshot and Growth Engine
4.2 Oncology Drug Market Overview
4.3 Chemotherapy
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Chemotherapy: Geographic Segmentation Analysis
4.4 Targeted Therapy
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Targeted Therapy: Geographic Segmentation Analysis
4.5 Immunotherapy
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Immunotherapy: Geographic Segmentation Analysis
4.6 Hormonal Therapy
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Hormonal Therapy: Geographic Segmentation Analysis
4.7 Others
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Others: Geographic Segmentation Analysis
Chapter 5: Oncology Drug Market by Application
5.1 Oncology Drug Market Snapshot and Growth Engine
5.2 Oncology Drug Market Overview
5.3 Blood Cancer
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Blood Cancer: Geographic Segmentation Analysis
5.4 Breast Cancer
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Breast Cancer: Geographic Segmentation Analysis
5.5 gastrointestinal Tract Cancer
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 gastrointestinal Tract Cancer: Geographic Segmentation Analysis
5.6 Prostate Cancer
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Prostate Cancer: Geographic Segmentation Analysis
5.7 Lung Cancer
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Lung Cancer: Geographic Segmentation Analysis
5.8 Skin Cancer
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Skin Cancer: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Oncology Drug Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ROCHE LTD
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 NOVARTIS AG
6.4 BRISTOL-MYERS SQUIBB
6.5 CELGENE CORPORATION
6.6 JOHNSON and JOHNSON
6.7 PFIZER INC.
6.8 ASTRA ZENCA PLC
6.9 ELI LILLY AND COMPANY.
6.10 GLAXOSMITHKLINE PLC
6.11 MERCK and CO.
6.12 SANOFI
6.13 AMGEN INC.
6.14 ABBVIE
Chapter 7: Global Oncology Drug Market By Region
7.1 Overview
7.2. North America Oncology Drug Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Chemotherapy
7.2.4.2 Targeted Therapy
7.2.4.3 Immunotherapy
7.2.4.4 Hormonal Therapy
7.2.4.5 Others
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Blood Cancer
7.2.5.2 Breast Cancer
7.2.5.3 gastrointestinal Tract Cancer
7.2.5.4 Prostate Cancer
7.2.5.5 Lung Cancer
7.2.5.6 Skin Cancer
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Oncology Drug Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Chemotherapy
7.3.4.2 Targeted Therapy
7.3.4.3 Immunotherapy
7.3.4.4 Hormonal Therapy
7.3.4.5 Others
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Blood Cancer
7.3.5.2 Breast Cancer
7.3.5.3 gastrointestinal Tract Cancer
7.3.5.4 Prostate Cancer
7.3.5.5 Lung Cancer
7.3.5.6 Skin Cancer
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Oncology Drug Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Chemotherapy
7.4.4.2 Targeted Therapy
7.4.4.3 Immunotherapy
7.4.4.4 Hormonal Therapy
7.4.4.5 Others
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Blood Cancer
7.4.5.2 Breast Cancer
7.4.5.3 gastrointestinal Tract Cancer
7.4.5.4 Prostate Cancer
7.4.5.5 Lung Cancer
7.4.5.6 Skin Cancer
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Oncology Drug Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Chemotherapy
7.5.4.2 Targeted Therapy
7.5.4.3 Immunotherapy
7.5.4.4 Hormonal Therapy
7.5.4.5 Others
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Blood Cancer
7.5.5.2 Breast Cancer
7.5.5.3 gastrointestinal Tract Cancer
7.5.5.4 Prostate Cancer
7.5.5.5 Lung Cancer
7.5.5.6 Skin Cancer
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East and Africa Oncology Drug Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Chemotherapy
7.6.4.2 Targeted Therapy
7.6.4.3 Immunotherapy
7.6.4.4 Hormonal Therapy
7.6.4.5 Others
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Blood Cancer
7.6.5.2 Breast Cancer
7.6.5.3 gastrointestinal Tract Cancer
7.6.5.4 Prostate Cancer
7.6.5.5 Lung Cancer
7.6.5.6 Skin Cancer
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Oncology Drug Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Chemotherapy
7.7.4.2 Targeted Therapy
7.7.4.3 Immunotherapy
7.7.4.4 Hormonal Therapy
7.7.4.5 Others
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Blood Cancer
7.7.5.2 Breast Cancer
7.7.5.3 gastrointestinal Tract Cancer
7.7.5.4 Prostate Cancer
7.7.5.5 Lung Cancer
7.7.5.6 Skin Cancer
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Oncology Drug Scope:
|
Report Data
|
Oncology Drug Market
|
|
Oncology Drug Market Size in 2022
|
USD XXX million
|
|
Oncology Drug CAGR 2023 - 2030
|
XX%
|
|
Oncology Drug Base Year
|
2022
|
|
Oncology Drug Forecast Data
|
2023 - 2030
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Roche Ltd, Novartis AG, Bristol-Myers Squibb, Celgene Corporation, Johnson and Johnson, Pfizer Inc., Astra Zenca Plc, Eli Lilly And Company., Glaxosmithkline Plc, Merck and Co., Sanofi, Amgen Inc., Abbvie.
|
|
Key Segments
|
By Type
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy
Others
By Applications
Blood Cancer
Breast Cancer
gastrointestinal Tract Cancer
Prostate Cancer
Lung Cancer
Skin Cancer
|
